Early bacterial and fungal infections in liver transplantation after oral selective bowel decontamination.
Hjortrup
A
A
Department of Transplantation, Rigshospitalet, Copenhagen, Denmark.
Rasmussen
A
A
Hansen
B A
BA
Høiby
N
N
Heslet
L
L
Moesgaard
F
F
Kirkegaard
P
P
D000293:Adolescent; D000328:Adult; D000667:Ampicillin / Q000627:therapeutic use; D000704:Analysis of Variance; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis; D000935:Antifungal Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000145:classification / Q000453:epidemiology* / Q000517:prevention & control; D002443:Ceftriaxone / Q000627:therapeutic use; D002444:Cefuroxime / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005243:Feces / Q000382:microbiology; D006084:Graft Rejection / Q000453:epidemiology; D006801:Humans; D007223:Infant; D016031:Liver Transplantation; D008875:Middle Aged; D009181:Mycoses / Q000453:epidemiology* / Q000517:prevention & control; D009761:Nystatin / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000453:epidemiology*; D012044:Regression Analysis; D012189:Retrospective Studies; D012307:Risk Factors; D014031:Tobramycin / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000935:Antifungal Agents; D009761:Nystatin; D002443:Ceftriaxone; D000667:Ampicillin; D002444:Cefuroxime; D014031:Tobramycin